CELEGHINI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 7.271
EU - Europa 3.006
AS - Asia 2.905
SA - Sud America 228
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 13.476
Nazione #
US - Stati Uniti d'America 7.197
SG - Singapore 1.077
PL - Polonia 805
CN - Cina 748
UA - Ucraina 442
SE - Svezia 408
IT - Italia 336
HK - Hong Kong 283
VN - Vietnam 226
FI - Finlandia 196
BR - Brasile 168
KR - Corea 156
TR - Turchia 153
GB - Regno Unito 143
FR - Francia 140
DE - Germania 113
BD - Bangladesh 108
RU - Federazione Russa 108
IE - Irlanda 89
BG - Bulgaria 72
CH - Svizzera 67
IN - India 47
CA - Canada 39
BE - Belgio 20
MX - Messico 20
NL - Olanda 20
MA - Marocco 19
IQ - Iraq 18
AR - Argentina 17
GR - Grecia 14
JP - Giappone 13
CL - Cile 12
ID - Indonesia 12
ES - Italia 9
CO - Colombia 8
PH - Filippine 8
ZA - Sudafrica 8
AT - Austria 7
PY - Paraguay 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
KE - Kenya 5
PE - Perù 5
TH - Thailandia 5
UZ - Uzbekistan 5
AM - Armenia 4
AU - Australia 4
EC - Ecuador 4
EU - Europa 4
SN - Senegal 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
EG - Egitto 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
PK - Pakistan 3
RO - Romania 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
HR - Croazia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
SR - Suriname 1
UG - Uganda 1
Totale 13.476
Città #
Fairfield 838
Woodbridge 737
Warsaw 732
Ashburn 672
Singapore 608
Ann Arbor 535
Houston 513
Chandler 415
Jacksonville 399
Wilmington 351
Seattle 334
San Jose 294
Hong Kong 281
Cambridge 273
Hefei 202
Seoul 153
Princeton 144
Izmir 139
Boardman 137
Beijing 133
Dallas 117
Chicago 94
Columbus 73
Dublin 72
Sofia 72
Lauterbourg 67
Zgierz 66
Helsinki 65
Bern 62
Trieste 62
Ho Chi Minh City 59
Los Angeles 57
Buffalo 54
Hanoi 54
Moscow 54
San Diego 46
Dearborn 43
Milan 43
The Dalles 43
Frankfurt am Main 41
New York 37
Santa Clara 32
Menlo Park 31
Des Moines 22
Nanjing 21
London 20
São Paulo 20
Guangzhou 18
Shanghai 18
Falls Church 16
Verona 16
Brussels 15
Casablanca 15
Council Bluffs 15
Ferrara 14
Orem 14
Phoenix 13
Denver 12
Jinan 12
Miano 12
Atlanta 11
Brooklyn 11
Hangzhou 11
Tokyo 11
Corinth 10
Da Nang 10
Dong Ket 10
Redwood City 10
Auburn Hills 9
Düsseldorf 9
Kunming 9
Norwalk 9
Rome 9
Nanchang 8
Redondo Beach 8
Vancouver 8
Washington 8
Amsterdam 7
Baghdad 7
Haiphong 7
Mexico City 7
Montreal 7
Naples 7
Sacile 7
Shenzhen 7
Tianjin 7
Xi'an 7
Chennai 6
Johannesburg 6
Portsmouth 6
Santiago 6
Toronto 6
Zhengzhou 6
Boston 5
Hebei 5
Kocaeli 5
Mumbai 5
North Bergen 5
Poplar 5
Shenyang 5
Totale 9.809
Nome #
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 454
Neuronal Dysfunction Associated with Cholesterol Deregulation. 435
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 387
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 354
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 344
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 317
Pre-eclampsia affects procalcitonin production in placental tissue 314
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 266
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 254
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 254
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 228
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 228
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 224
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 224
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 217
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity 215
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 212
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. 207
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 207
Potential role of circulating microRNAs as early markers of preeclampsia 206
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 205
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. 202
PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. 201
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 198
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 194
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. 193
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-Rays absorptiometry 192
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells. 190
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 189
Potential pathogenetic implications of cyclooxygenase-2 overexpression in Bchronic lymphoid leukemia cells 187
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 184
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 183
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 180
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 177
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. 175
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. 171
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 169
Recent advances in the therapeutic perspectives of Nutlin-3 169
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 166
Differential effects of stromal derived factor-1a (SDF-1a) on early and late stages of human megakaryocytic development. 162
Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells 162
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL). 160
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 158
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. 158
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 157
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. 157
In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity. 156
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells. 155
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 151
Thrombopoietin enhances the aIIbb3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. 150
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. 149
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. 145
In vitro senescence and apoptotic cell death of human megakaryocytes. 142
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line. 142
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 142
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 141
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. 141
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. 139
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 139
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 135
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 133
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells. 131
Levels of circulating TNF‑related apoptosis‑inducing ligand in celiac disease 131
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells. 130
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 128
NF-κB pathways in hematological malignancies 125
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 120
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. 118
The engagement of CD4 surface antigen in the HEL haemopoietic cell line up-regulates the transforming growth factor-b1 (TGF-b1) promoter activity. 114
In situ polymerase chain reaction tecnique revealed by flow cytometry as a tool for gene detection. 107
Morphological features of apoptosis in hematopoietic cells belonging to the T-lymphoid and myeloid lineages. 104
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. 103
Totale 13.657
Categoria #
all - tutte 37.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022792 37 51 32 67 31 80 44 23 97 91 74 165
2022/20231.166 94 125 84 170 118 231 1 108 172 6 44 13
2023/2024627 93 48 37 55 48 52 120 101 5 5 30 33
2024/20251.272 20 29 65 183 132 169 42 76 171 121 93 171
2025/20263.404 252 198 288 229 258 351 566 124 384 423 189 142
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 13.657